Quantcast
Last updated on April 16, 2014 at 5:49 EDT

Latest prostate cancer treatment Stories

2014-03-04 12:25:43

Urology Device Market Set to Reach Over $2.6 Billion by 2022, According to Findings from Decision Resources Group BURLINGTON, Mass., March 4, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States market for urological devices will expand to over $2.6 billion by 2022. While some formerly high-growth segments, including vaginal slings, benign prostatic hyperplasia (BPH) treatment devices and prostate cancer treatment devices, declined in 2013, various factors will...

2013-04-25 00:20:40

PMI initiates Transurethral Ultrasound Ablation (TULSA) clinical trial for novel, minimally invasive device for localized prostate cancer treatment  TORONTO, April 25, 2013 /PRNewswire/ - Profound Medical Inc. today announced the commencement of its Health Canada approved, multi-center TULSA (Transurethral Ultrasound Ablation) clinical trial for its minimally invasive, novel ablation device used to facilitate prostate cancer treatment. In the world's first procedure of its kind,...

2013-01-25 12:25:07

NEW YORK, Jan. 25, 2013 /PRNewswire/ -- The impact of prostate cancer on American men will be significant in 2013, according to the "Cancer Facts & Figures 2013" report by the American Cancer Society (ACS) (http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf). The ACS projects that nearly 240,000 new cases of prostate cancer will account for 28 percent of all male cancers this year. Despite the disease's prevalence, prostate cancer...

2013-01-08 16:23:51

NEW YORK, Jan. 8, 2013 /PRNewswire/ -- Prostate cancer diagnoses may bring out the fight in men but patients need to know which punch to throw first. When diagnosed early, prostate cancer is highly treatable and patients most often choose between robotic prostate removal surgery or radiation for prostate cancer, including external beam radiation therapy (EBRT) and brachytherapy seed radiation. (Logo: http://photos.prnewswire.com/prnh/20130108/NY39190LOGO ) Three concerns drive the...

2012-09-13 10:29:21

NEW YORK, Sept. 13, 2012 /PRNewswire/ -- Despite the best efforts of prostate cancer experts, the media, and widespread Prostate Cancer Awareness Month articles, the facts of prostate cancer recovery remain unclear to many. Dr. David Samadi, developer of the SMART (Samadi Modified Advanced Robotic Technique) robotic prostate surgery, helps men work through the common fears, worries, and even misconceptions about prostate cancer treatment and understand the beneficial role of surgery....

2012-08-29 10:22:26

PITMAN, N.J., Aug. 29, 2012 /PRNewswire/ -- Men with prostate cancer may fear that they will never have sex again. What they are feeling can be disturbing, but there is hope. Jeffrey Albaugh, PhD, APRN, CUCNS, addresses sexual issues during and after prostate cancer treatment in a new book written specifically for patients and their partners: Reclaiming Sex & Intimacy After Prostate Cancer: A Guide for Men and Their Partners. All treatments for prostate cancer can result in diminished...

2012-08-16 10:24:11

NEW YORK, Aug. 16, 2012 /PRNewswire/ -- A patient, a surgeon, and a robot walk into the operating room - but it's no joke. With prostate cancer as the punch line, preserving erectile function and enjoying sex after prostatectomy surgery is no laughing matter. Many men with prostate cancer are eager to get it out, but potential trade-offs are a big concern. How can I be sure my sex life will live as long as I do? In truth, prostate cancer treatment and recovery is highly individual, but one...

2012-07-19 10:23:27

NEW YORK, July 19, 2012 /PRNewswire/ -- Life expectancy is the new metric for PSA testing and prostate cancer, according to the American Society of Clinical Oncology (ASCO). Dr. David Samadi, SMART robotic prostate cancer surgeon, explains how newly released ASCO guidelines put into writing what leading prostate cancer treatment experts have been espousing for years. (Photo: http://photos.prnewswire.com/prnh/20120719/NY43296) The ASCO advises men with a life expectancy of less than ten...

2012-07-02 22:10:54

Prostate cancer patients with cardiovascular disease were 52 per cent more likely to regret their treatment choices than men without problems with their heart or veins, according to a study published in the July issue of the urology journal BJUI International. Research led by Harvard Medical School, USA, looked at 795 men with recurrent cancer in the Comprehensive Observational Multicenter Prostate Adenocarcinoma (COMPARE) registry. "Treatment regret can have an adverse impact on a...

2012-06-22 06:22:47

NEW YORK, June 22, 2012 /PRNewswire/ -- When weighing prostate cancer treatment options, potential side effects such as urinary control and sexual potency are the hot buttons. Seldom discussed, though significantly more damaging, is bone disease. Early diagnosis of prostate cancer, and the right treatment path, can drastically reduce a man's risk of developing prostate cancer-related bone disease. (Photo: http://photos.prnewswire.com/prnh/20120622/NY28935 ) World renowned prostate surgery...